The reported statements, read against the company's own industry.
What stands out
Valued far above the size of its business
Financials view
Market Capitalization
6.21BCNY
922.71M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue (TTM)
371.80MCNY
55.22M · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
-45.04%
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -711.3%.Updated Aug 19, 2026
Beta
1.09x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-64.79%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
6.21BCNY
922.71M · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
13.68BCNY
2.03B · vs all stocks (USD)
Updated Aug 19, 2026
Forward P/E
44.05x
Updated Aug 19, 2026
Price to Sales (TTM)
17.91x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 16.71×.Updated Aug 19, 2026
Enterprise to Revenue
36.80x
Updated Aug 19, 2026
Enterprise to EBITDA
-8.89x
Updated Aug 19, 2026
Gross Margin
8.18%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -64.58%.Updated Aug 19, 2026
Profit Margin
-45.04%
Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -711.3%.Updated Aug 19, 2026
Operating Margin
-27.22%
Updated Aug 19, 2026
Return on Assets (TTM)
-10.86%
Updated Aug 19, 2026
Revenue (TTM)
371.80MCNY
55.22M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
0.5170CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
-45.80%
Updated Aug 19, 2026
Gross Profit (TTM)
-240.13MCNY
-35.66M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
-1.54BCNY
-228.58M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
-2.64BCNY
-392.78M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
234.69%
Updated Aug 19, 2026
Operating Cash Flow (TTM)
-159.55MCNY
-23.70M · vs all stocks (USD)
Updated Aug 19, 2026
Payout Ratio
0.00%
Updated Aug 19, 2026
Minority Interest (Equity)
893.40MCNYFY2025 · Dec 31, 2025
Revenue
465.35MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
674.93MCNYFY2025 · Dec 31, 2025
Gross Profit
-209.57MCNYFY2025 · Dec 31, 2025
Operating Income
-516.83MCNY
-76.76M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-2.55BCNYFY2025 · Dec 31, 2025
Income Tax Expense
185.05MCNYFY2025 · Dec 31, 2025
Net Income
-2.74BCNYFY2025 · Dec 31, 2025
EBIT
-2.29BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-222.27MCNYFY2025 · Dec 31, 2025
Research & Development
26.48MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
34.43MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
13.11MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.96MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
261.14MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-3.77CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-3.77CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
719.89MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
719.89MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-2.74BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
19.26MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-1.47BCNYFY2025 · Dec 31, 2025
Free Cash Flow
-1.61BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
167.43MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-2.74BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
265.76MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
776.14MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
223.01MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-135.15MCNYFY2025 · Dec 31, 2025
Sale of Investments
495.67MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-1.15MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
359.36MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.72BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-2.38BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-314.82MCNYFY2025 · Dec 31, 2025
Other Financing Charges
379.02MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-596.80MCNYFY2025 · Dec 31, 2025
Shares Outstanding
719.89MSharesUpdated Aug 19, 2026
Float Shares
449.80MSharesUpdated Aug 19, 2026
% Held by Insiders
39.01%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
0.81%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
511.27MCNY
75.93M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
0.7100CNYUpdated Aug 19, 2026
Total Debt (MRQ)
6.64BCNY
986.14M · vs all stocks (USD)
Updated Aug 19, 2026
Current Ratio (MRQ)
0.4490x
Updated Aug 19, 2026
Book Value per Share (MRQ)
-2.78CNYUpdated Aug 19, 2026
Total Assets
8.05BCNY
1.20B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
3.18BCNYFY2025 · Dec 31, 2025
Total Liabilities
9.11BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
4.87BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.23BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
6.88BCNYFY2025 · Dec 31, 2025
Cash
167.43MCNYFY2025 · Dec 31, 2025
Cash Equivalents
266.78MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
434.21MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
164.64MCNYFY2025 · Dec 31, 2025
Accounts Receivable
580.64MCNYFY2025 · Dec 31, 2025
Inventory
349.64MCNYFY2025 · Dec 31, 2025
Accounts Payable
1.71BCNYFY2025 · Dec 31, 2025
Short-term Debt
3.60BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.11BCNYFY2025 · Dec 31, 2025
Long-term Debt
1.67BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
29.18MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
719.89MCNYFY2025 · Dec 31, 2025
Retained Earnings
-6.33BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
-1.06BCNY
-157.32M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
5.97CNYUpdated Aug 19, 2026
52-Week High
26.00CNYUpdated Aug 19, 2026
52-Week Change
-64.79%
vs all stocks
Updated Aug 19, 2026
Beta
1.09x
vs all stocks
Updated Aug 19, 2026
50-Day MA
8.82CNYUpdated Aug 19, 2026
200-Day MA
12.23CNYUpdated Aug 19, 2026
Avg 10-Day Volume
16.13MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
15.61MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
-3.67CNYUpdated Aug 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Valued far above the size of its businessSignificant
Price-to-Sales: 17.91Revenue Growth YoY: -0.46
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Companies that share the same coordination system — how they create, deliver, or capture value.